Tissue Engineering & Regenerative Medicine

Omid Panahi was graduated from Centro Escolar University in 2013 in the field of Doctor of Dental Medicine (DMD), and MSc Oral and Maxillofacial Surgery at Yeditepe University, Istanbul, Turkey. He has published 8 books and more than 50 papers in reputed journals and has been serving as an Editorial Board Member of ISI journals.

Research interests:Regenerative dentistry, tissue bioengineering, oral surgery.

Elena Salvaterra is a bioethicist with a deep experience in human and non human biobanking. She earned a Ph.D in Bioethics in 2004 (University of Milano, Italy) and a MA in Clinical Psychology (2020). She worked many years in the research field as bioethicist by serving academic and health care organizations.

Clinical Psychology, human biobanking

He is a Professor in pharmacology department of Uiversity of Illinois, Chicago

Recovery of endothelial barrier integrity after vascular injury is vital for endothelial barrier function and vascular homeostasis. Endothelial dysfunction plays a critical role in the initiation and progression of vascular diseases such as acute lung injury/acute respiratory distress syndrome, and atherosclerosis. A part of the research in the lab is to elucidate the molecular mechanisms of endothelial regeneration and restoration of endothelial barrier integrity following inflammatory lung vascular injury, understand the mechanisms of action of stem/endothelial progenitor cells-mediated endothelial regeneration, vascular repair, and neovascularization using the unique mouse model with endothelial cell-restricted deletion of FoxM1 (JCI, 116:2333-43, 2006; JEM, 207:1675-85, 2010) and other genetically modified animal models

Esmaiel Jabbari completed his PhD at Purdue University and postdoctoral studies at Monsanto, Rice University, and Mayo Clinic. He is Full Professor of Chemical and Biomedical Engineering and Director of Biomimetic Materials and Tissue Engineering Laboratory at University of South Carolina. He is internationally known for his work on synthesis and processing of cell-responsive polymers and hydrogels for applications in tissue engineering and regenerative medicine. He received the Berton Rahn Award from the AO Foundation in 2012 and the Stephen Milam Award from the Oral and Maxillofacial Surgery Foundation in 2008. He was elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE) in 2013. He has published >230 books, book chapters, peer-reviewed journal articles, and conference proceedings, and presented >260 seminars at national and international conferences on biomaterials, tissue engineering, and drug delivery. He has mentored >130 visiting scholars, post-doctoral researchers, doctoral students, and undergraduate students. He is a member of numerous scientific organizations including BMES, SFB, TERMIS, MRS, EMBS, ACS, AIChE, and AACR.

.

Diana is director of the Anderson University Center for Cancer Research and is excited about the research opportunities it can offer, as well as the local internships she can refer students to.She is a Director of Education at Susan G. Komen Mountains to Midlands Affiliate.

Biology, Cellular Biology, Genetics, Microbiology

Roger R. Markwald, Ph.D., MUSC Cell Biology and Anatomy Department chairman and professor, received the American Association of Anatomy’s highest scientific accolade on April 5 during its annual meeting in San Diego. The Henry Gray award was co-sponsored by the American Association of Anatomists and Lippincott Williams & Wilkins, which recognizes unique and meritorious contributions and achievements in the field of Anatomical Sciences by a distinguished AAA member.

My laboratory has pursued studies on the cell and molecular mechanisms of heart development that utilized in vivo dynamic labeling studies to demonstrate that heart development is progressive, irreversible and occurs by the addition of new segments including ones derived from extracardiac sources. Three dimensional culture assays were also developed that faithfully recapitulated in vivo morphogenetic processes which permitted identification of: (1) a novel heart forming field that gave origin to the outflow track at the arterial pole of the heart (, (2) specific growth factors of the TGFβ supergene as inducers of the outflow track and the transformation of specific populations of endothelial cells into multiple progenitor cells of internal partitions that divide the heart into right and left sides a and their respective valves and (3) specific matricellular proteins (periostin and CCN1,2) as ligands that activate integrin-linked, nodal intracellular kinase pathways in valvuloseptal progenitor cells that promote their differentiation into fibroblasts and regulate cytoskeletal changes that promote their remodeling into sculpted leaflets. Modifications of the culture system have also permitted the functional assessment of the viscoelastic properties of developing valves and the role of biomechanical signaling in cardiac cell and matrix differentiation.

.

He Controlled cardiac lineage differentiation of embryonic stem cells, iPSCs & adult cardiac stem cells, iPSC reprograming and characterization Electrophysiological and functional maturity of stem cell-derived cardiomyocytes, Stem cell tissue engineering and Applications and mechanisms of stem cell-based therapy for cardiovascular diseases

Dr. Mironov studied Medicine at the Ivanovo Sate Medical University, Ivanovo, Russia and graduated as MD in 1977. He received his PhD degree in Developmental Biology 1980 at the Moscow Pirogov State Medical Institute in 1980. After that he worked at different position in Germany, USA and Brazil. Last 5 years he serves as Chief Scientific Officer of private bioprinting company 3D Bioprinting Solutions, Moscow, Russia. He bioprinted world first functional vascularized mouse organ – mouse thyroid gland in 2015 and bioprinted a first 3D tissue (human cartilage) in Space at the International Space Station in December of 2018.

3D Bio printing, 3D Tissue regeneration

José Luis Carrillo Gamboa has completed his PhD from National Autonomous University of México in the School of Medicine. He is the Director and Founder of Mexico. He is an Academic Coordinator in Orthopedics at Hospital H+ Querétaro and; advisory member of University of Valley of México. He has published results in osteoarthritis with stem cells.

Regenerative Medicine, 3D Bio printing

Dr Kampon Sriwatanakul is the president of Vita Stem Co. Ltd., Bangkok and an internationally recognized pioneer of stem cell therapy. He is currently engaged in research and development projects related to the application of mesenchymal stem cell in the anti-aging and regenerative medicine.

Stem Cell Therapy, Regenerative Medicine

Alain Chapel is a Scientific Investigator at IRSN, Laboratory of Radiopathology and Experimental Therapies.For 25 years, he has been developing gene and cell therapy using non-human primates, immune-tolerant mice and rats to protect against the side effects of radiation. He collaborates with clinicians to develop strategies for treatment of patients after radiotherapy overexposures. He has participated in the first establishment of proof of concept of the therapeutic efficacy of Mesenchymal stem cells (MSCs) for the treatment of hematopoietic deficit, radiodermatitis and over dosages of radiotherapy. He has contributed to the first reported correction of deficient hematopoiesis in patients (graft failure and aplastic anemia) thanks to intravenous injection of MSCs restoring the bone marrow microenvironment, mandatory to sustain hematopoiesis after total body irradiation. He is scientific investigator of Clinical phase II trial evaluating the efficacy of systemic MSC injections for the treatment of severe and chronic radiotherapy-induced abdomino-pelvic complications refractory to standard therapy (NCT02814864Hirsch Index 26.

Regenerative medicine, Cell therapy, scaffold, radiotherapy

Dr.Omid Panahi , Graduated from Centro Escolar University on 2013 in field of Doctor of Dental Mediciene( DMD), and MSc Oral and maxillofacial surgery at yeditepe university, Istanbul, turkey. He has published more than 40 papers in reputed journals and has been serving as an editorial board member of isi journals.

Oral implant, Oral surgery, Regenerative dentistry

Dr. Brij. M. Gandhi, M.Sc., Ph.D. is presently CEO and founder of Neo BioMed Services (www.neobiomed.com), providing services and consultancy in health areas and regulatory issues related to biopharmaceuticals, pharmaceuticals, including stem cell and regenerative medicine. Dr. Gandhi had his Masters in Biochemistry from PAU and Ph.D. in Experimental Medicine from the University of Bergan, Norway. He was trained at the Massachusetts Institute of Technology, USA; London School of Hygiene and Tropical Medicine, London; National Institutes of Health, Maryland, USA; Hvidovre Hospital, Copenhagen and University of Bergan, Norway. Dr. Gandhi retired in 2006 as Adviser to the Government of India, Ministry of Science and Technology, Department of Biotechnology, managing promotion and policy related issues in biotechnology related to international collaborations, medical biotechnology, infrastructure development, animals and aquaculture biotechnology. Prior to that, Dr. Gandhi served as Research Scientist at All India Institute of Medical Sciences, New Delhi. Dr. Gandhi continues to serve as Advisor / Director to a number of institutions/pharma and biopharma industries with an experience of about 51 years of active service, as research scientist, science manager, adviser/consultant and has over 155 publications.

Immunology of parasitic, bacterial and viral infections including amoebic diseases; hepatitis; liver diseases, IVD; food and nutritional health; stem cells; CBRNe

Dr.Omid Panahi , Graduated from Centro Escolar University on 2013 in field of Doctor of Dental Mediciene( DMD), and MSc Oral and maxillofacial surgery at yeditepe university, Istanbul, turkey. He has published more than 40 papers in reputed journals and has been serving as an editorial board member of isi journals.

Oral Surgery, Oral Implant, Regenerative dentistry.

MS. SUCHI is an experienced International Pre School Principal/Manager who picked up Laughter exercises from many coaches around the world. She then designed ‘Laughter Therapy' which is being used in many places such as hospitals and Senior Activity Centres. She provides individual and group therapy in educational and home settings. A former Manager / Trainer is now engaging in building social awareness about Holistic approach for recovery. Be it Depression, Anxiety caused by physical or emotional pain, Death in the family and the harm the unhappiness brings to people, families and communities. Her aim is to encourage people to seek help early and get on the path to recovery. Her works has been featured in local press, TV and Radio and has been an invited speaker at various community clubs and educational Institutions. She has also been awarded by MINDS and various community clubs in recognition of her social work.

Prof Wolvetang obtained his PhD from the University of Amsterdam in 1996. Since 2009 He is a senior group leader at the Australian Institute for Bio-engineering and Nanotechnology of the University of Queensland (Australia). Prof Wolvetang is director of the UQ Centre “stem cell ageing and regenerative engineering”, leads the “Cell reprogramming Australia” collaborative network, and is a principal investigator in the ARC Center of Excellence “Stem Cells Australia. He was awarded the 2014 LSQ regenerative medicine prize and was co-recipient of the 2016 Eureka Prize for international collaboration and has published >110 peer reviewed manuscripts.

Regenerative Medicine, Tissue Engineering

Peter A. Everts is the Chief Scientific Officer at EmCyte Corporation with a demonstrated history of working in the medical practice industry. He is Skilled in Medical Devices for biological therapies for use in Orthobiology-MSK, Spine, Chronic Wound Care, Cardiac Surgery, Reconstructive Surgery, Facial Aesthetics, Hair Regrowth, and other Regenerative Medicine applications.Peter A. Everts is an Strong research professional graduated from the University of Utrecht PhD program, and International ATMO, San Antonio, TX, USA.

Regenerative Medicine, Tissue Regeneration, Platelet Rich Plasma, bone marrow and adipose mesenchymal cells

He was born in 1947, education in mechanical engineering / textile technology at University of Stuttgart (Germany), 1974 Scientist Institute for Textile and Process Engineering (ITV Denkendorf) 1980 – 1998 Supervisor Biomedical Engineering Group, 1998 Director of ITV and Full Professor for Textile Technology / Biomedical Engineering, add. 2001 CEO ITV Product Service GmbH, 2006 Director Interuniversital Center for Biomedical Engineering Stuttgart-Tuebingen, Vicepresident and President German Soc. for Biomaterials Member of the Coucil Europ. Soc. Biomaterials Director and Member of the Board of several Center of Excellences Biomedical Engineering

bio materials for soft tissue replacement, Implants, artificial organs, tissue engineering, wound care

Denis Barritault graduated in Math and Physics, completed his Ph.D. in biochemistry in Paris University. Post doctoral in molecular immunology at Pasteur Institute and NYU as NIH Fogarty Fellow he joined INSERM unit in Paris as developmental biologist. He made the first description and patents of FGF extracted from retina in 1979 and 82 as skin and cornea healing agent, became full professor at Paris East University in 1985, founded and directed a CNRS Laboratory on cell and tissue regeneration until 2003. He is now President of OTR3, Emeritus Professor and author in over 200 publications and 29 patents.

tissue regeneration, molecular immunology

Professor Oleksandr Kukharchuk, M.D. (Doctor of Medical Science) has accomplished 15 yrs of progenitor cells therapy experience in Ukraine, and 7 yrs in India. Scientific Publications: 250, patents: 17. He developed regulatory documents for stem cells therapy to implement as official treatment in Ukraine. Has innovated technique, how to overcome biggest challenge in transplantation – “Rejection of foreign tissue”. Prof. Oleksandr Kukharchuk guided clinical trials for evaluation of progenitor cells transplantation efficacy in diabetes mellitus, chronic limb ischemia, myocardiodystrophy, liver cirrhosis, male infertility, aging and pancreonecrosis. He is author of the book “Stem cells: Experiment, Theory, Clinic. Embryonic, mesenchymal, neural, hematopoetic stem cells”. Approval Committee member of Health Ministry “Program of transplantation in Ukraine” 2006-2010, Director of Coordination Centre for Organs, Tissues and Cells Transplantation of the Ukraine Health Ministry, 2006-2010; Member of European Society of Transplantology from 2006; Member of European Society of Gene and Cell Therapy from 2012.

Biotechnology & Regenerative Medicine: stem cells 3D culture, stem cells exosomes, stem cells growth factors

Yaegaki K is a Doctor of Dental Science. He has completed his PhD in Medicine from Kureme University Medical Biochemistry and Post-doctoral studies from University of British Columbia. He was trained as Oral Maxillofacial Surgeon at School of Medicine Kurume University. His specialty was facial injuries and cancer. He is the Director and Head of Oral Health at Nippon Dental University, which is the oldest dental school in Asia, also a Dean of PhD program. He has published more than 100 papers and 20 books. He has been serving as an Editorial Board Member of repute.

stem cell research, regenerative medicine, tissue engineering etc

Takashi Tsuji has completed PhD from Niigata University and worked in JT Inc. He was Professor of Tokyo University of Science (2000-14) and is Team leader of RIKEN BDR (2014-Present). He is Visiting Professor of Kobe University, Tokyo Dental University, Kwansei University, Tokyo University of Science and Keio University. He has published more than 100 papers including review in journals and has been serving as an editorial board member of Scientific Reports. He is a Director of Organ Technologies Inc.

Regenerative Medicine, Organ Regeneration

Dr. Purita is director of Institute of Regenerative and Molecular Orthopedics (www.stemcellorthopedic.com) in Boca Raton, Florida. Dr. Purita is a pioneer in the use of Stem Cells and Platelet Rich Plasma. He received a B.S. and MD degree from Georgetown Univ. Dr. Purita is board certified in Orthopedics by ABOS. He is a Fellow American College of Surgeons, Fellow American Academy Orthopedic Surgeons, and a Fellow American Academy of Pain Management. He has lectured and taught extensively throughout the world on the use of Stem Cells and Platelet Rich Plasma. He has helped countries develop Stem Cell policies.

Stem cell,regenerative medicine

lain Chapel is a Scientific Investigator at IRSN, Laboratory of Radiopathology and Experimental Therapies.For 25 years, he has been developing gene and cell therapy using non-human primates, immune-tolerant mice and rats to protect against the side effects of radiation. He collaborates with clinicians to develop strategies for treatment of patients after radiotherapy overexposures. He has participated in the first establishment of proof of concept of the therapeutic efficacy of Mesenchymal stem cells (MSCs) for the treatment of hematopoietic deficit, radiodermatitis and over dosages of radiotherapy. He has contributed to the first reported correction of deficient hematopoiesis in patients (graft failure and aplastic anemia) thanks to intravenous injection of MSCs restoring the bone marrow microenvironment, mandatory to sustain hematopoiesis after total body irradiation. He is scientific investigator of Clinical phase II trial evaluating the efficacy of systemic MSC injections for the treatment of severe and chronic radiotherapy-induced abdomino-pelvic complications refractory to standard therapy (NCT02814864Hirsch Index 26.

Regenerative medicine, Cell therapy, scaffold, radiotherapy